换一批
换一批Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.
作者：
Carla,Nester [1]
;
Dima A,Decker [2]
;
Matthias,Meier [3]
;
Shakil,Aslam [4]
;
Andrew S,Bomback [5]
;
Fernando,Caravaca-Fontán [6]
;
Terence H,Cook [7]
;
David L,Feldman [8]
;
Veronique,Fremeaux-Bacchi [9]
;
Daniel P,Gale [10]
;
Ann,Gooch [4]
;
Sally,Johnson [11]
;
Christoph,Licht [12]
;
Mohit,Mathur [13]
;
Matthew C,Pickering [7]
;
Manuel,Praga [14]
;
Giuseppe,Remuzzi [15]
;
Viknesh,Selvarajah [16]
;
Richard J,Smith [17]
;
Hossein,Tabriziani [18]
;
Nicole,van de Kar [19]
;
Yaqin,Wang [20]
;
Edwin,Wong [21]
;
Kirtida,Mistry [22]
;
Mark,Lim [23]
;
Cesia,Portillo [23]
;
Seyi,Balogun [23]
;
Howard,Trachtman [24]
;
Aliza,Thompson [22]
作者单位：
Department of Pediatrics, Division of Nephrology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
[1]
Apellis Pharmaceuticals Inc., Waltham, Massachusetts.
[2]
Novartis Inc., Basel, Switzerland.
[3]
BioCryst Pharmaceuticals Inc., Durham, North Carolina.
[4]
Columbia University Irving Medical Center, New York, New York.
[5]
Research Institute "Hospital 12 de Octubre," Madrid, Spain.
[6]
Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
[7]
National Kidney Foundation, New York, New York.
[8]
Hôpital Europeén Georges Pompidou, Paris, France.
[9]
Department of Renal Medicine, University College of London, London, United Kingdom.;Rare Kidney Disease Registry (RaDaR), Bristol, United Kingdom.
[10]
Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.
[11]
The Hospital for Sick Children, Toronto, Ontario, Canada.
[12]
Visterra Inc., Waltham, Massachusetts.
[13]
Department of Medicine, Nephrology Department, Complutense University, Madrid, Spain.
[14]
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
[15]
Research and Early Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
[16]
Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
[17]
Natera Inc., Austin, Texas.
[18]
Radboud Institute for Molecular Life Sciences, Amalia Children's Hospital, Radboud University, Nijmegen, The Netherlands.
[19]
Novartis Inc., East Hanover, New Jersey.
[20]
Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
[21]
Center for the Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
[22]
Kidney Health Initiative, American Society of Nephrology, Washington, DC.
[23]
Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.
[24]
DOI
10.2215/CJN.0000000000000505
PMID
38829708
发布时间
2024-11-20
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
